Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
INOVIO's INO-5401 in Combination with PD-1 Inhibitor Libtayo(R) (cemiplimab) Demonstrates 85% of Newly Diagnosed Glioblastoma Patients Are Alive 12 Months Following Treatment
2020-05-14 19:00
SciMount announces FDA approval of SMP-100's IND application for the treatment of Irritable Bowel Syndrome
2020-05-14 18:00
Novartis Singapore returns Job Support Scheme payout worth SGD3.7 Million; aids community efforts against COVID-19
2020-05-14 15:18
Experts Underscore Essential Role for Patient Blood Management in and beyond the COVID-19 Pandemic
2020-05-14 14:00
Halodine(R) Nasal and Oral Antiseptics Show Rapid Antiviral Activity Against SARS-CoV-2 (COVID-19)
2020-05-14 09:26
TYVYT® (Sintilimab Injection) ORIENT-2 Study Met its Primary Endpoint of Overall Survival in the Second-Line Treatment of Patients with Advanced or Metastatic Esophageal Squamous Cell Carcinoma
2020-05-14 07:30
Hanwha Helps the Fight Against COVID-19 by Providing Life Park, a Smart Training Institute in the City of Yongin, Gyeonggi Province in Korea, as a Treatment Center
2020-05-14 07:00
Breakthrough Innovation in Cancer Care From Merck Pipeline to Be Presented at ASCO 2020
2020-05-14 06:46
Hetero Enters Into a Licensing Agreement With Gilead Sciences, Inc. for the Manufacturing and Distribution of "Remdesivir" in 127 Countries, Including India, for COVID-19
2020-05-14 01:56
Telehealth to Experience Massive Growth with COVID-19 Pandemic, Says Frost & Sullivan
2020-05-14 01:05
DERMALOG Fever Detection Protects Draegerwerk AG Production
2020-05-13 21:10
First Patient Dosed with I-Mab's CD73 Antibody TJD5 in Phase 1/2 Clinical Trial in China for Advanced Solid Tumors
2020-05-13 20:00
Fluxergy Announces $30 Million to Expand Manufacturing Capacity of Its One-hour Point-of-care Diagnostic Testing System in Response to COVID-19
2020-05-13 18:41
Ascletis' THR- beta Agonist ASC41 Receives Approval for Clinical Trials of NASH Indication
2020-05-13 18:30
CMAB Biopharma's development and manufacturing platform successfully completes Q-1802 bispecific antibody project for QureBio within 9 months
2020-05-13 18:29
Cipla Enters Into a Licensing Agreement With Gilead to Expand Access to COVID-19 Treatment
2020-05-13 17:51
Big Start helps businesses secure PPE gear as global demand spikes
2020-05-13 14:00
Low-dose radiographs could reveal typical lung changes
2020-05-13 08:20
ChemPartner Assists the Mount Sinai Health System in Producing Reagent for COVID-19 Research
2020-05-12 23:03
China Biologic Products to Report First Quarter 2020 Financial Results
2020-05-12 20:30
1
567
568
569
570
571
958